Position in GILD
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$232,788,038
+$7,905,652 QoQ
Shares Held
1,670,288
-8.8% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Candriam S.C.A. holds $1,534,786,576 across 9 Drug Manufacturers - General names. GILD ranks #3 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
417,282 | $383,803,465 | |
| 2 | ABBV |
AbbVie Inc.
|
1,144,668 | $248,953,843 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
1,670,288 | $232,788,038 | |
| 4 | JNJ |
Johnson & Johnson
|
798,815 | $195,262,338 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,322,654 | $159,102,049 | |
| 6 | AMGN |
Amgen Inc
|
395,351 | $139,104,249 | |
| 7 | BIIB |
Biogen Inc.
|
381,768 | $69,989,527 | |
| 8 | PFE |
Pfizer Inc
|
1,992,586 | $55,951,814 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $232,788,038 | 1,670,288 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $224,882,386 | 1,832,185 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $179,864,067 | 1,620,397 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $167,395,739 | 1,509,838 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $176,416,449 | 1,574,444 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $159,182,698 | 1,723,316 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $175,081,982 | 2,088,287 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $138,586,710 | 2,019,920 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $167,385,699 | 2,285,129 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $181,481,599 | 2,240,237 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $112,998,728 | 1,507,856 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $129,615,940 | 1,681,795 | Shares | Other | 2023-08-08 | |
| 2023-03-31 | $138,723,184 | 1,671,968 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $140,322,425 | 1,634,507 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $124,052,667 | 2,010,904 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $125,490,308 | 2,030,259 | Shares | Other | 2022-08-03 | |
| 2022-03-31 | $103,935,601 | 1,748,286 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $115,211,230 | 1,586,713 | Shares | Other | 2022-02-10 | |
| 2021-09-30 | $108,799,127 | 1,557,611 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $109,632,418 | 1,592,106 | Shares | Other | 2021-07-20 | |
| 2021-03-31 | $142,505,013 | 2,204,936 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $128,459,804 | 2,204,940 | Shares | Other | 2021-01-22 | |
| 2020-09-30 | $121,690,669 | 1,925,790 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $130,030,522 | 1,690,025 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $168,733,095 | 2,256,997 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||